Bharat Book Bureau Provides the Trending Industry Research Report on“Therapeutic Nuclear Medicines Market - Global Outlook and Forecast 2022-2028”under Life Sciences Market Research Report. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
This report contains market size and forecasts of Therapeutic Nuclear Medicines in global, including the following market information:
Global Therapeutic Nuclear Medicines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Therapeutic Nuclear Medicines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Therapeutic Nuclear Medicines companies in 2021 (%)
The global Therapeutic Nuclear Medicines market was valued at 1719.4 million in 2021 and is projected to reach US$ 5230.4 million by 2028, at a CAGR of 17.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radium-223 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Nuclear Medicines include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus and Acrotech Biopharma., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Therapeutic Nuclear Medicines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Nuclear Medicines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Nuclear Medicines Market Segment Percentages, by Type, 2021 (%)
Global Therapeutic Nuclear Medicines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Nuclear Medicines Market Segment Percentages, by Application, 2021 (%)
Global Therapeutic Nuclear Medicines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Nuclear Medicines Market Segment Percentages, By Region and Country, 2021 (%)
Rest of Europe
Rest of Asia
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Therapeutic Nuclear Medicines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Therapeutic Nuclear Medicines revenues share in global market, 2021 (%)
Key companies Therapeutic Nuclear Medicines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Therapeutic Nuclear Medicines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
China Isotope & Radiation
Browse our full report with Table of Content : https://www.bharatbook.com/report/1265540/therapeutic-nuclear-medicines-market-global-outlook-and-forecast
About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Industry Study, Industry Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]